Colour Me Mad

Trishla Surana (Co-founder & CEO) is the inventor, product visionary, and brand identity creator whose broad feet and consequent shoe-finding difficulties catalysed the business, and whose design sensibility drove Colour Me Mad's original "children's doodles as footwear art" concept before the pivot to orthopedic technology. Rajeev Surana (Co-founder & Marketing Head) is from Raipur, Chhattisgarh and his background in marketing and business development gave Colour Me Mad the commercial discipline that a designer-founded company needs to scale. Rajeev said: "I am from Raipur, a boy whose city has given him the passion and courage to dream big. It truly gives me immense pleasure that I have been able to chart my journey from my hometown Raipur to Shark Tank India." The founding history has two distinct phases: 2014–2016: Colour Me Mad as lifestyle footwear brand personalised flip-flops with printed fabric and children's doodle designs.

Colour Me Mad / Your Foot Doctor is India's first comprehensive foot health technology brand designing and manufacturing customised orthopedic insoles (for flat feet, plantar fasciitis, heel pain, knee pain, and ankle pain), customised footwear (that can be made in 10 minutes, a first in India), socks, foot oils, and online foot consultation services targeting the 40% of Indians with flat feet and the 70% who wrongly accept foot pain as normal through a direct-to-consumer website, at-home service, and doctor partnership model.

Amount Asked: ₹40 lakhs Equity Offered: 10% Implied Pre-Money Valuation: ₹4 crore

Colour Me Mad's pitch was the second of Episode 33 (Finale Week Day 3) opening with what the founders described as the most important body part not normally highlighted: the foot. The theatrical opening "your feet are beautiful, don't keep them on the floor" used Bollywood-dialogue energy to command immediate attention before pivoting to the serious medical reality: 70% of Indians accept foot pain as normal; 2 in 5 have flat feet. They started their pitch by telling sharks their feet are very beautiful so they should not keep them on the floor to avoid them from being dirty. Although it was a filmy dialogue they explained how there are multiple problems of foot pain and the solution to that. The product demonstration showing the customised footwear process, the insole options, the colourful designs communicated both the functional orthopedic value (foot health correction) and the aesthetic differentiation (vibrant, non-clinical-looking products that people would actually want to wear).

Aman Gupta exited first with the most culturally relevant scepticism. Aman remarks that considering there are so many problems in India, wouldn't being flat-footed be low on the list for most people? Aman's "priority of problems" concern is real Indian consumers who are managing economic stress, food insecurity, and healthcare access challenges may not prioritise foot pain treatment. Anupam Mittal gave the most strategically actionable exit advice. Anupam agreed on the point that shoes are not their product they should work on insoles. Today he is out and wished them all the best. Peyush Bansal was the most commercially specific advisor despite exiting. Peyush agrees that it's a significant problem and mentions that scaling might be an issue. He suggests that the company should focus on insoles and let go of the footwear side of the business. Ashneer Grover exited on distribution channel concerns. Namita Thapar was the most aligned Shark her Emcure Pharmaceuticals background and healthcare distribution networks gave her specific understanding of orthopedic product adoption through doctor recommendations and clinical endorsement pathways.

Namita offered ₹40 lakhs for 25% equity. Rajeev and Trishla's counter: ₹40 lakhs for 20% equity. CMM Footwear deal got closed by Namita Thapar at 25% equity by investing ₹40 lakhs in the company.

On-Screen Deal: YES (Namita Thapar, ₹40L for 25%)